135 related articles for article (PubMed ID: 6780634)
1. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.
Käyhty H; Karanko V; Peltola H; Sarna S; Mäkelä PH
J Infect Dis; 1980 Dec; 142(6):861-8. PubMed ID: 6780634
[TBL] [Abstract][Full Text] [Related]
2. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization.
Ceesay SJ; Allen SJ; Menon A; Todd JE; Cham K; Carlone GM; Turner SH; Gheesling LL; DeWitt W; Plikaytis BD
J Infect Dis; 1993 May; 167(5):1212-6. PubMed ID: 8486957
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses of human infants to three doses of group A Neisseria meningitidis polysaccharide vaccine administered at two, four, and six months of age.
Gold R; Lepow ML; Goldschneider I; Draper TF; Gotschlich EC
J Infect Dis; 1978 Dec; 138(6):731-5. PubMed ID: 105053
[TBL] [Abstract][Full Text] [Related]
4. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children.
King WJ; MacDonald NE; Wells G; Huang J; Allen U; Chan F; Ferris W; Diaz-Mitoma F; Ashton F
J Pediatr; 1996 Feb; 128(2):196-202. PubMed ID: 8636811
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.
Peltola H; Mäkelä H; Käyhty H; Jousimies H; Herva E; Hällström K; Sivonen A; Renkonen OV; Pettay O; Karanko V; Ahvonen P; Sarna S
N Engl J Med; 1977 Sep; 297(13):686-91. PubMed ID: 408682
[TBL] [Abstract][Full Text] [Related]
6. Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination.
Mohammed I; Onyemelukwe GC; Obineche EN; Gupta N; Oyeyinka GO
J Infect; 1984 Sep; 9(2):197-202. PubMed ID: 6438245
[TBL] [Abstract][Full Text] [Related]
7. [Immunological effectiveness of a dried group-A meningococcal polysaccharide vaccine].
Alliluev AP; Kotel'nikova OV; Chernyshova TF; Skirda TA; Kuvakina VI
Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):106-12. PubMed ID: 6428089
[TBL] [Abstract][Full Text] [Related]
8. An ELISA study of the antibody response after vaccination with a combined meningococcal group B polysaccharide and serotype 2 outer membrane protein vaccine.
Rosenqvist E; Tjade T; Frøholm LO; Frasch CE
NIPH Ann; 1983 Dec; 6(2):139-49. PubMed ID: 6427704
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of O-acetyl-negative and -positive polysaccharide vaccines for infections with Neisseria meningitidis group C in infants.
Pichichero M; Anderson P; Gotschlich E; Kamm J; McMullen A; Nielsen S
J Infect Dis; 1985 Oct; 152(4):850-1. PubMed ID: 3930623
[No Abstract] [Full Text] [Related]
10. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children.
Gold R; Lepow ML; Goldschneider I; Draper TF; Gotshlich EC
J Infect Dis; 1979 Nov; 140(5):690-7. PubMed ID: 118997
[TBL] [Abstract][Full Text] [Related]
12. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Jennings HJ
Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
[No Abstract] [Full Text] [Related]
13. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.
Lepow ML; Goldschneider I; Gold R; Randolph M; Gotschlich EC
Pediatrics; 1977 Nov; 60(5):673-80. PubMed ID: 411104
[TBL] [Abstract][Full Text] [Related]
14. Group C Neisseria meningitidis variant polysaccharide vaccines in children.
Steinhoff MC; Lewin EB; Gotschlich EC; Robbins JB
Infect Immun; 1981 Oct; 34(1):144-6. PubMed ID: 6795122
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of the meningococcal vaccine from Group C capsular polysaccharide].
González Enríquez J; García Comas L; Alcaide Jiménez JF; Sáenz Calvo A; Conde Olasagasti J
Rev Esp Salud Publica; 1997; 71(2):103-26. PubMed ID: 9546855
[TBL] [Abstract][Full Text] [Related]
16. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976).
Parke JC; Schneerson R; Robbins JB; Schlesselman JJ
J Infect Dis; 1977 Aug; 136 Suppl():S51-6. PubMed ID: 408433
[TBL] [Abstract][Full Text] [Related]
17. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.
Herva E; Leinonen M; Käyhty H; Mäkelä PH; Vetoniemi-Korhonen SL
J Infect; 1983 Jan; 6(1):55-60. PubMed ID: 6411822
[TBL] [Abstract][Full Text] [Related]
18. [Observations on the immune responses of infants and young children to group A meningococcal polysaccharide vaccine].
Zhao JW
Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Feb; 4(1):12-4. PubMed ID: 6411345
[No Abstract] [Full Text] [Related]
19. Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein.
Thiesen B; Greenwood B; Brieske N; Achtman M
Vaccine; 1997 Feb; 15(2):209-19. PubMed ID: 9066040
[TBL] [Abstract][Full Text] [Related]
20. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
Skevakis L; Frasch CE; Zahradnik JM; Dolin R
J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
